Acute leukemia: diagnosis, management, and potential for cure
Canadian Family Physician Medecin De Famille Canadien
|January 22, 2011
Summary
Acute leukemia, a cancer of blood-forming tissues, has different types. Acute lymphoblastic leukemia in children shows high survival rates with chemotherapy, while acute myelogenous leukemia in adults has a less favorable prognosis but offers potential cures with advanced treatments.
Area of Science:
- Hematology
- Oncology
- Pediatric Oncology
Background:
- Acute leukemia is a rare malignant condition.
- It arises from the abnormal proliferation of blood cell precursors.
- Two main types exist: acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML).
Purpose of the Study:
- To summarize the epidemiology and prognosis of acute leukemia.
- To highlight treatment outcomes for pediatric ALL and adult AML.
Main Methods:
- Review of current medical literature.
- Analysis of survival statistics for different acute leukemia subtypes.
- Overview of contemporary treatment modalities.
Main Results:
- Acute lymphoblastic leukemia (ALL) is more prevalent in children.
- Modern chemotherapy achieves long-term survival or cure in 60%-70% of pediatric ALL cases.
- Acute myelogenous leukemia (AML) predominantly affects adults with a less favorable outlook.
- Bone-marrow transplantation offers potential cure for selected adult AML patients.
Conclusions:
- Significant progress has been made in treating childhood acute lymphoblastic leukemia.
- While challenging, acute myelogenous leukemia treatment is advancing, with transplantation offering hope for specific patient groups.
- Further research into novel therapies for acute leukemia is warranted.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...